Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

(2013) C.M. Legendre et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Hemolytic Uremic Syndrome in Germany: Presentation and Short-term Outcome in Children

(2012) S. Loos et al.   CLINICAL INFECTIOUS DISEASES

Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Associated With Organic Fenugreek Sprouts, France, June 2011

(2012) L. A. King et al.   CLINICAL INFECTIOUS DISEASES

Association Between Azithromycin Therapy and Duration of Bacterial Shedding Among Patients With Shiga Toxin–Producing Enteroaggregative Escherichia coli O104:H4

(2012) Martin Nitschke et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Immunoadsorption in patients with haemolytic uraemic syndrome

(2012) Christian Combe et al.   LANCET

E. coli O104:H4 German outbreak: a missed opportunity

(2012) Piero Ruggenenti et al.   Nature Reviews Nephrology

STEC-HUS, atypical HUS and TTP are all diseases of complement activation

(2012) Marina Noris et al.   Nature Reviews Nephrology

Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed

(2012) D. Karpman   NEPHROLOGY DIALYSIS TRANSPLANTATION

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

(2012) Jan T. Kielstein et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011

(2012) Y. H. Grad et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Thrombotic Microangiopathy: Current Knowledge and Outcomes With Plasma Exchange

(2012) William F. Clark   SEMINARS IN DIALYSIS

Treating Shiga toxin induced haemolytic uraemic syndrome

(2012) F. Artunc   BMJ-British Medical Journal

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

(2012) J. Menne et al.   BMJ-British Medical Journal

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

(2011) A.-l. Stahl et al.   BLOOD

Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis

(2011) M. Morigi et al.   JOURNAL OF IMMUNOLOGY

“HUS diary” of a German nephrologist during the current EHEC outbreak in Europe

(2011) Sigrid Harendza   KIDNEY INTERNATIONAL

Recent outbreak of hemolytic uremic syndrome in Germany

(2011) Ulrich Kunzendorf et al.   KIDNEY INTERNATIONAL

A German outbreak of haemolytic uraemic syndrome

(2011) Piero Ruggenenti et al.   LANCET

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial

(2011) Andreas Greinacher et al.   LANCET

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study

(2011) Edin Colic et al.   LANCET

Escherichia coli O104:H4 south-west France, June 2011

(2011) Patricia Mariani-Kurkdjian et al.   LANCET INFECTIOUS DISEASES

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

(2011) Martina Bielaszewska et al.   LANCET INFECTIOUS DISEASES

As E. coli continues to claim lives, new approaches offer hope

(2011) Elie Dolgin   NATURE MEDICINE

Eculizumab in Severe Shiga-Toxin–Associated HUS

(2011) Anne-Laure Lapeyraque et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in Germany

(2011) Christina Frank et al.   NEW ENGLAND JOURNAL OF MEDICINE

German Outbreak ofEscherichia coliO104:H4 Associated with Sprouts

(2011) Udo Buchholz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Apheresis in the Treatment of Hemolytic Uremic Syndrome in View of Pathophysiological Aspects

(2011) Rolf Bambauer et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Practical Considerations for Planning a Therapeutic Apheresis Procedure

(2010) Suresh G. Shelat   AMERICAN JOURNAL OF MEDICINE

Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the apheresis applications committee of the American Society for Apheresis

(2010) Zbigniew M. Szczepiorkowski et al.   JOURNAL OF CLINICAL APHERESIS

Complement in Typical Hemolytic Uremic Syndrome

(2010) Dorothea Orth et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome

(2009) J. M. Thurman et al.   Clinical Journal of the American Society of Nephrology

Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome

(2009) Dorothea Orth et al.   JOURNAL OF IMMUNOLOGY